Results 61 to 70 of about 1,153,166 (189)

Defensin: The immune system regulatory factor against peripheral nerve disease

open access: yesBrain‐X, Volume 3, Issue 1, March 2025.
Peripheral nerve disease is a common disorder that can lead to sensory, motor, and autonomic dysfunction, with common symptoms including pain, loss of sensation, lack of coordination, muscle weakness, and atrophy. Defensins (which can be divided into mammal, insect, and plant defensins), as regulatory factors of the immune system, can influence ...
Tiantian Qi   +8 more
wiley   +1 more source

Burkholderia cepacia: medical, taxonomie and ecological issues

open access: yes, 1996
The increasing challenge posed by multiresistant saprophytes in medical microbiology is strikingly demonstrated by the emergence of Burkholderia (formerly Pseudomonas) cepacia as an opportunist pathogen in immunocompromised patients, particularly ...
Vandamme, Peter   +2 more
core   +1 more source

DNA Methylation Epigenetically Regulates Gene Expression in Burkholderia cenocepacia and Controls Biofilm Formation, Cell Aggregation, and Motility

open access: yesmSphere, 2020
Respiratory tract infections by the opportunistic pathogen Burkholderia cenocepacia often lead to severe lung damage in cystic fibrosis (CF) patients.
Ian Vandenbussche   +5 more
doaj   +3 more sources

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

open access: yesCell Discovery, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of Coronavirus disease 2019 (COVID-19). However, the microbial composition of the respiratory tract and other infected tissues as well as their possible pathogenic ...
Huanzi Zhong   +32 more
doaj   +1 more source

Clinical Detection and Management of Colorectal Cancer Concerning the Gut Microbiome

open access: yesScientifica, Volume 2025, Issue 1, 2025.
Colorectal cancer (CRC) is a prevalent malignancy worldwide and a leading cause of cancer‐related mortality, influenced by both genetic predisposition and environmental factors. Gut dysbiosis, characterized by an imbalance in the gut microbiome, has been identified as a significant contributor to CRC progression. Although considerable progress has been
Hamed Eraghieh Farahani   +3 more
wiley   +1 more source

228 Cepacia syndrome caused by Burkholderia cenocepacia ST-32 strain: risk factors

open access: yesJournal of Cystic Fibrosis, 2011
227* CT scores correlate with survival in cystic fibrosis patients awaiting lung transplantation M. Loeve1,2, P.T.W. van Hal3, P. Robinson4, M. Aitken5, J.D. Dodd6, M. de Bruijne7,8, W.C. Hop7, H.A.W.M. Tiddens7, CT CFS Study Group. 1Erasmus MC − Sophia Children’s Hospital, Pediatric Pulmonology, Rotterdam, Netherlands; 2Erasmus MC, Radiology ...
Fila, L.   +3 more
openaire   +1 more source

The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre [PDF]

open access: yes, 2008
Background: This study reviews the impact of changing infection control practices at the Manchester Adult Cystic Fibrosis Centre (MACFC) upon the epidemiology of Burkholderia species infections.Methods: We reviewed strain and genomovar typing of all ...
Doherty, Catherine J.   +5 more
core   +1 more source

Stucture of macromolecules from Gram-negative bacteria involved in elicitation of plant immune system [PDF]

open access: yes, 2010
This project was entirely focused on increasing the knowledge of the structure/activity relationships of LPS in plant immune system and their roles in instauration of important biological process like symbiosis.
Leone, Maria Rosaria
core   +1 more source

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches

open access: yesFrontiers in Microbiology, 2017
Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing into a life-threatening systemic infection known as cepacia syndrome ...
Viola C. Scoffone   +6 more
doaj   +1 more source

Cystic fibrosis year in review 2023

open access: yesPediatric Pulmonology, Volume 59, Issue 12, Page 3106-3116, December 2024.
Abstract This past year, there were many important advances for patients with cystic fibrosis (CF). Of the many publications related to CF in 2023, there was further evaluation of highly effective modulator therapy, new assessments and guidelines for clinical manifestations and therapies for CF, advances in newborn screening and diagnosis, and ...
David V. Swetland, Adrienne P. Savant
wiley   +1 more source

Home - About - Disclaimer - Privacy